ENWEI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.81 CNY | +1.59% |
|
+0.22% | -4.41% |
| May. 14 | Enwei Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
| Apr. 21 | Enwei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 692M 95.5M | Sales 2023 | 785M 108M | Capitalization | 2.91B 402M |
|---|---|---|---|---|---|
| Net income 2022 | 67M 9.25M | Net income 2023 | 86M 11.88M | EV / Sales 2022 | 3.2 x |
| Net cash position 2022 | 578M 79.84M | Net cash position 2023 | 392M 54.13M | EV / Sales 2023 | 3.21 x |
| P/E ratio 2022 |
33.4
x | P/E ratio 2023 |
33.7
x | Employees | 1,552 |
| Yield 2022 |
4.02% | Yield 2023 |
1.93% | Free-Float | 25.34% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.59% | ||
| 1 week | +0.22% | ||
| 1 month | -3.86% | ||
| 3 months | +15.01% | ||
| 6 months | -10.83% | ||
| Current year | -4.41% |
1 week
25.89
27.28
1 month
25.8930.51
Current year
18.8930.51
1 year
18.8934.99
3 years
18.8940.54
5 years
18.8940.54
10 years
18.8940.54
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 26.81 | +1.59% | 927,261 |
| 24-05-30 | 26.39 | -0.71% | 557,864 |
| 24-05-29 | 26.58 | +0.72% | 911,324 |
| 24-05-28 | 26.39 | -3.16% | 639,964 |
| 24-05-27 | 27.25 | +1.87% | 924,196 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotes
Enwei Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of proprietary Chinese medicines and chemical medicines. The Company focuses on gynecological products, pediatric medicines, respiratory medicines and other fields. The Company's main products include Jieeryin lotion, Jieeryin ointment, Jieeryin effervescent tablets, Shanmai Jianpi oral liquid, Qingjing capsules and Danxiong Tongmai granules. Its products are mainly sold through direct sales and e-commerce. The Company principally conducts its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -4.41% | 370M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 301331 Stock
